Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCOT: Stem Cell Transplant vs Cyclophosphamide in Scleroderma
NCT00114530Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jun 2005
- Primary completion
- Apr 2016
- Modality
- Stem Cell Therapies
- Countries
- 2
01
Overview
A Phase 3 trial of autologous hematopoietic stem cells in systemic sclerosis (SSc), sponsored by National Institute of Allergy and Infectious Diseases. Started Jun 2005; status: completed.
02
Drugs
autologous hematopoietic stem cells
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT00114530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00114530.